2Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283. 被引量：1
3Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68. 被引量：1
4Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586. 被引量：1
5Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265. 被引量：1
6Diepolder HM;Jung MC;Keller E.A vigorous virus-specific CD-4 T cell response may contribute to the association of HLADR13 with viral clearance in hepatitis B[J],1998. 被引量：1
7Thursz MR;Kwiatkowski D;Allsopp CE.Association between an MHC class Ⅱ allele and clearance of hepatitis B virus in the Gambia[J],1995. 被引量：1
8Cotrina M;Buti M;Jardi R.Study of HLA- Ⅱ antigens in chronic hepatitis C and B and in acute hepatitis B,1997. 被引量：1
9Hohler T;Gerken G;Notghi A.HLA-DRB1 * 1301 and * 1302 protect against chronic hepatitis B[J],1997. 被引量：1
10Bhimma R;Hammond MG;Coovadia HM.HLA class Ⅰ and Ⅱ in black children with hepatitis B virus-associated membranous nephropathy[J],2002. 被引量：1
